CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. The company was founded in 2017 and is headquartered in Houston, Texas. Organ Targeted Therapeutics The company’s lead drug candidate, Berubicin, is proposed for the … Continue reading “CNS Pharmaceuticals Inc. (NASDAQ: CNSP)”
New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.
Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.
Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.